Cargando…

Decision Aids for Preventive Treatment Alternatives for BRCA1/2 Mutation Carriers: a Systematic Review

Introduction Women with a pathogenic BRCA1/2 mutation have a markedly increased lifetime risk of developing breast and/or ovarian cancer. The current preventive treatment alternatives that are offered are an intensified breast cancer screening programme and risk-reducing operations. Before deciding...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krassuski, Lisa Marlene, Kautz-Freimuth, Sibylle, Vennedey, Vera, Rhiem, Kerstin, Schmutzler, Rita K., Stock, Stephanie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2021
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8216782/ https://www.ncbi.nlm.nih.gov/pubmed/34168381 http://dx.doi.org/10.1055/a-1326-1792

Ejemplares similares

Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
por: Krassuski, Lisa, et al.
Publicado: (2019)

Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2021)

Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2022)

Effectiveness of evidence-based decision aids for women with pathogenic BRCA1 or BRCA2 variants in the german health care context: results from a randomized controlled trial
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2023)

“You Always Have It in the Back of Your Mind”—Feelings, Coping, and Support Needs of Women with Pathogenic Variants in Moderate-Risk Genes for Hereditary Breast Cancer Attending Genetic Counseling in Germany: A Qualitative Interview Study
por: Stracke, Claudia, et al.
Publicado: (2022)

Long-term survival of a BRCA2 mutation carrier following second ovarian cancer relapse using PARPi therapy: A case report
por: Bredow, Kathrin, et al.
Publicado: (2022)

Nurse-led decision coaching by specialized nurses for healthy BRCA1/2 gene mutation carriers - adaptation and pilot testing of a curriculum for nurses: a qualitative study
por: Berger-Höger, Birte, et al.
Publicado: (2022)

Assessing Psychological Morbidity in Cancer-Unaffected BRCA1/2 Pathogenic Variant Carriers: A Systematic Review
por: Isselhard, Anna, et al.
Publicado: (2023)

Non-small cell neuroendocrine carcinoma of the ovary in a BRCA2-germline mutation carrier: A case report and brief review of the literature
por: Herold, Natalie, et al.
Publicado: (2018)

Coping Self-Efficacy and Its Relationship with Psychological Morbidity after Genetic Test Result Disclosure: Results from Cancer-Unaffected BRCA1/2 Mutation Carriers
por: Isselhard, Anna, et al.
Publicado: (2023)

Psychological factors and the uptake of preventative measures in BRCA1/2 pathogenic variant carriers: results of a prospective cohort study
por: Dick, Julia, et al.
Publicado: (2022)

Implementation and evaluation of a nurse-led decision-coaching program for healthy breast cancer susceptibility gene (BRCA1/2) mutation carriers: a study protocol for the randomized controlled EDCP-BRCA study
por: Isselhard, A., et al.
Publicado: (2020)

Feasibility of structured endurance training and Mediterranean diet in BRCA1 and BRCA2 mutation carriers – an interventional randomized controlled multicenter trial (LIBRE-1)
por: Kiechle, Marion, et al.
Publicado: (2017)

Satisfaction and Quality of Life of Healthy and Unilateral Diseased BRCA1/2 Pathogenic Variant Carriers after Risk-Reducing Mastectomy and Reconstruction Using the BREAST-Q Questionnaire
por: Herold, Natalie, et al.
Publicado: (2022)

Decision aids for female BRCA mutation carriers: a scoping review protocol
por: McGarrigle, Sarah A, et al.
Publicado: (2021)

The evolution of health literacy assessment tools: a systematic review
por: Altin, Sibel Vildan, et al.
Publicado: (2014)

A qualitative study on barriers to evidence-based practice in patient counseling and advocacy in Germany
por: Altin, Sibel, et al.
Publicado: (2015)

Uptake Rates of Risk-Reducing Surgeries for Women at Increased Risk of Hereditary Breast and Ovarian Cancer Applied to Cost-Effectiveness Analyses: A Scoping Systematic Review
por: Simões Corrêa Galendi, Julia, et al.
Publicado: (2022)

Barriers in the implementation of interprofessional continuing education programs – a qualitative study from Germany
por: Altin, Sibel V, et al.
Publicado: (2014)

Prevalence of BRCA1 and BRCA2 Mutations in Patients with Primary Ovarian Cancer – Does the German Checklist for Detecting the Risk of Hereditary Breast and Ovarian Cancer Adequately Depict the Need for Consultation?
por: Ataseven, Beyhan, et al.
Publicado: (2020)

Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia‐like phenotype, and no chromosome fragility
por: Keupp, Katharina, et al.
Publicado: (2019)

Parental views on acute otitis media (AOM) and its therapy in children - results of an exploratory survey in German childcare facilities
por: Kautz-Freimuth, Sibylle, et al.
Publicado: (2015)

Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial
por: Kiechle, Marion, et al.
Publicado: (2016)

Precursor fractions of neurotensin and enkephalin might point to molecular mechanisms of cancer risk modulation during a lifestyle-intervention in germline BRCA1/2 gene mutation carriers
por: Grill, Sabine, et al.
Publicado: (2021)

Physical activity and Mediterranean diet as potential modulators of osteoprotegerin and soluble RANKL in gBRCA1/2 mutation carriers: results of the lifestyle intervention pilot study LIBRE-1
por: Neirich, Leonie, et al.
Publicado: (2021)

Management of the asymptomatic BRCA mutation carrier
por: Teller, Paige, et al.
Publicado: (2010)

Lifestyle intervention in BRCA1/2 mutation carriers: study protocol for a prospective, randomized, controlled clinical feasibility trial (LIBRE-1 study)
por: Kiechle, Marion, et al.
Publicado: (2016)

Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction
por: Wappenschmidt, Barbara, et al.
Publicado: (2012)

A patient decision aid for risk‐reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing
por: Harmsen, Marline G., et al.
Publicado: (2017)

The risk of contralateral breast cancer in patients from BRCA1/2 negative high risk families as compared to patients from BRCA1 or BRCA2 positive families: a retrospective cohort study
por: Rhiem, Kerstin, et al.
Publicado: (2012)

Providing ambulatory healthcare for people aged 80 and over: Views and perspectives of physicians and dentists from a qualitative survey
por: Herrler, Angélique, et al.
Publicado: (2022)

Recommendations and Choices for BRCA Mutation Carriers at Risk for Ovarian Cancer: A Complicated Decision
por: Lewis, Kelsey E., et al.
Publicado: (2018)

Ambulatory Care Preferences of Older People Age 80 and Over: A Systematic Review of Qualitative Studies
por: Herrler, Angélique, et al.
Publicado: (2020)

Which features of ambulatory healthcare are preferred by people aged 80 and over? Findings from a systematic review of qualitative studies and appraisal of confidence using GRADE-CERQual
por: Herrler, Angélique, et al.
Publicado: (2022)

What matters to people aged 80 and over regarding ambulatory care? A systematic review and meta-synthesis of qualitative studies
por: Herrler, Angélique, et al.
Publicado: (2021)

Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variant
por: Brédart, Anne, et al.
Publicado: (2021)

Cancer risks among BRCA1 and BRCA2 mutation carriers
por: Levy-Lahad, E, et al.
Publicado: (2007)

The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers
por: Iqbal, J, et al.
Publicado: (2012)

Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
por: Warner, Ellen
Publicado: (2018)

Haplotype analysis in German families with recurrent BRCA1 and BRCA2 mutations
por: Wappenschmidt, B, et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_fuis49m262rbsga2a7nn3u94cg